نتائج البحث - "Effie Skrinos"

1

Supp Figure 1 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

المؤلفون: Niall C. Tebbutt, John M. Mariadason, Effie Skrinos, Alysson Wann, Timothy J. Price, Rachel Wong, Stephen Brown, Geoffrey Chong, Jessica Da Gama Duarte, Peter Savas, Fiona Chionh, Jennifer Mooi

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f27d605d36dc2837f821834ee1b464b
https://doi.org/10.1158/1078-0432.22483950.v1

View record in OpenAIRE

2

Supp Figure 2 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

المؤلفون: Niall C. Tebbutt, John M. Mariadason, Effie Skrinos, Alysson Wann, Timothy J. Price, Rachel Wong, Stephen Brown, Geoffrey Chong, Jessica Da Gama Duarte, Peter Savas, Fiona Chionh, Jennifer Mooi

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a93307e3f49119d12ba7f7bd4af5b82
https://doi.org/10.1158/1078-0432.22483947

View record in OpenAIRE

3

Supp Figure 3 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

المؤلفون: Niall C. Tebbutt, John M. Mariadason, Effie Skrinos, Alysson Wann, Timothy J. Price, Rachel Wong, Stephen Brown, Geoffrey Chong, Jessica Da Gama Duarte, Peter Savas, Fiona Chionh, Jennifer Mooi

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043fdea44cd56ce967dac93dc73fffd3
https://doi.org/10.1158/1078-0432.22483944

View record in OpenAIRE

4

Supplementary Tables from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

المؤلفون: Niall C. Tebbutt, John M. Mariadason, Effie Skrinos, Alysson Wann, Timothy J. Price, Rachel Wong, Stephen Brown, Geoffrey Chong, Jessica Da Gama Duarte, Peter Savas, Fiona Chionh, Jennifer Mooi

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6716d476d43230054feab526474207c
https://doi.org/10.1158/1078-0432.22483938

View record in OpenAIRE

5

Supplementary Legend from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

المؤلفون: Niall C. Tebbutt, John M. Mariadason, Effie Skrinos, Alysson Wann, Timothy J. Price, Rachel Wong, Stephen Brown, Geoffrey Chong, Jessica Da Gama Duarte, Peter Savas, Fiona Chionh, Jennifer Mooi

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68f411c213a6e87d6ee96b2253f72a1a
https://doi.org/10.1158/1078-0432.22483941.v1

View record in OpenAIRE

6

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

المؤلفون: Niall C. Tebbutt, Effie Skrinos, Peter Savas, Alysson Wann, Fiona Chionh, Geoffrey Chong, Stephen L. Brown, Jessica Da Gama Duarte, Timothy J. Price, Rachel Wong, Jennifer Mooi, John M. Mariadason

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 27(8)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Bevacizumab, Colorectal cancer, Recombinant Fusion Proteins, Population, Phases of clinical research, Angiogenesis Inhibitors, Kaplan-Meier Estimate, Risk Assessment, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Humans, education, Aged, Aged, 80 and over, education.field_of_study, business.industry, Cancer, Combination chemotherapy, Middle Aged, medicine.disease, Progression-Free Survival, Oxaliplatin, 030104 developmental biology, 030220 oncology & carcinogenesis, FOLFIRI, Female, business, Colorectal Neoplasms, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bd9b21d31fce978bdbf1caf1902cdcd
https://pubmed.ncbi.nlm.nih.gov/33514526

View record in OpenAIRE

7

Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study

المؤلفون: Rebecca Y. Tay, Yvonne Yeung, Niall C. Tebbutt, Carmel Murone, Fiona Chionh, Effie Skrinos, David K. Lau, Jennifer Mooi, John M. Mariadason, Timothy J. Price

المصدر: British Journal of Cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a99b43f2ac5604bd734ec7555b7e7b6
https://doi.org/10.1038/s41416-018-0021-1

View record in OpenAIRE

8

Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer

المؤلفون: Andrew M. Scott, Alexander Dobrovic, Timothy J. Price, Geoff Chong, Arun Azad, Kate Fluck, Niall C. Tebbutt, Terrance Grant Johns, Renato Salemi, Val Gebski, Andrew Weickhardt, Effie Skrinos, John M. Mariadason, Nick Pavlakis

المصدر: Journal of Clinical Oncology. 30:1505-1512

مصطلحات موضوعية: Male, Oncology, Cancer Research, Time Factors, Colorectal cancer, Cetuximab, Kaplan-Meier Estimate, medicine.disease_cause, Epidermal growth factor, Antineoplastic Combined Chemotherapy Protocols, Molecular Targeted Therapy, Epidermal growth factor receptor, Erlotinib Hydrochloride, Aged, 80 and over, biology, Antibodies, Monoclonal, Drug Synergism, Middle Aged, ErbB Receptors, Treatment Outcome, Female, KRAS, Erlotinib, Colorectal Neoplasms, Signal Transduction, medicine.drug, Adult, STAT3 Transcription Factor, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, Transfection, Disease-Free Survival, Proto-Oncogene Proteins p21(ras), Gefitinib, Cell Line, Tumor, Proto-Oncogene Proteins, Internal medicine, medicine, Humans, Protein Kinase Inhibitors, neoplasms, Aged, Cell Proliferation, Analysis of Variance, business.industry, Australia, medicine.disease, digestive system diseases, Drug Resistance, Neoplasm, Mutation, Quinazolines, ras Proteins, biology.protein, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f692a338983f8abce9fa691d6866a52
https://doi.org/10.1200/jco.2011.38.6599

View record in OpenAIRE

9

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

المصدر: Proceedings of the National Academy of Sciences. 104:4071-4076

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3e28e712a4f814ec60667b9de4160ed
https://doi.org/10.1073/pnas.0611693104

View record in OpenAIRE

10

Dual targeting of vascular endothelial growth factor-A (VEGF-A) and angiopoietins (Ang) without chemotherapy in metastatic colorectal cancer (mCRC): Results of the VENGEANCE study

المؤلفون: Timothy J. Price, Rachel Wong, Jennifer Mooi, Geoffrey Chong, Niall C. Tebbutt, Effie Skrinos, Stephen C.W. Brown

المصدر: Journal of Clinical Oncology. 33:3533-3533

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::057bc118e13bddad839db72674c82034
https://doi.org/10.1200/jco.2015.33.15_suppl.3533

View record in OpenAIRE

11

Phase II study of everolimus monotherapy as first-line treatment in advanced biliary tract cancer: RADichol

المؤلفون: Guangying Fang, Timothy J. Price, Hoanh Tran, Carmel Murone, Niall C. Tebbutt, Fiona Chionh, Yvonne Yeung, Andrew M. Scott, Effie Skrinos, John M. Mariadason

المصدر: Journal of Clinical Oncology. 32:4101-4101

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Pathology, Chemotherapy, Poor prognosis, Biliary tract cancer, Everolimus, business.industry, medicine.medical_treatment, Phases of clinical research, First line treatment, Biliary tract, Internal medicine, medicine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::25dbcbd1ee03ebf849b4f8f5fd418ddc
https://doi.org/10.1200/jco.2014.32.15_suppl.4101

View record in OpenAIRE

12

DUX study: A phase II study of evaluating dual targeting of the EGFR using the combination of cetuximab and erlotinib in patients with chemotherapy refractory metastatic colorectal cancer

المؤلفون: Geoff Chong, Timothy J. Price, Alexander Dobrovic, Nick Pavlakis, Andrew Weickhardt, Renato Salemi, Effie Skrinos, Niall C. Tebbutt, Andrew M. Scott, John M. Mariadason

المصدر: Journal of Clinical Oncology. 28:3533-3533

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b4b8cbd1a1a5a815316c7cb176d0188d
https://doi.org/10.1200/jco.2010.28.15_suppl.3533

View record in OpenAIRE

13

A phase I single dose escalation trial of ch806 in patients with advanced tumors expressing the 806 antigen

المؤلفون: S Gill, Anthony T. Papenfuss, Effie Skrinos, Andrew M. Scott, Bridget Chappell, Fook-Thean Lee, L. J. Old, Carmel Murone, T. Saunder, Zhanqi Liu

المصدر: Journal of Clinical Oncology. 24:13028-13028

مصطلحات موضوعية: Chimeric antibody, Cancer Research, biology, business.industry, medicine.drug_class, Monoclonal antibody, Molecular biology, Epitope, Oncology, Antigen, biology.protein, Dose escalation, Medicine, In patient, Epidermal growth factor receptor, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::aa10af2e536b2c95e1e265efc767426c
https://doi.org/10.1200/jco.2006.24.18_suppl.13028

View record in OpenAIRE

تنقيح النتائج